Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Macrocyclic compounds as TRK kinase inhibitors

Macrocyclic compounds as TRK kinase inhibitors

US Patent 9840519 · Granted Dec 12, 2017

Estimated economic value: $29,601,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Bridged tricyclic carbamoylpyridone compounds and uses thereof2025
Fused ring heteroaryl compounds as RIPK1 inhibitors2025
Antiviral pyrazolopiridinone compounds2025
Heterocyclic compounds and their use for treatment of helminthic infections and 2025
Fused ring heteroaryl compounds and use thereof2025
Bridged tricyclic carbamoylpyridone compounds and their pharmaceutical use2025
FGFR3 inhibitor compounds2025
MCL1 inhibitors2025
Substituted pyridotriazine compounds and uses thereof2025
N4-phenyl-quinazoline-4-amine derivatives and related compounds as ErbB type I r2024
MCL-1 inhibitors2024
10-(di(phenyl)methyl)-4-hydroxy-8,9,9A,10-tetrahydro-7H-pyrrolo[1′,2′:4,5]pyrazi2024